Opportunity Information: Apply for W81XWH 14 PCRP SIDA
Apply for W81XWH 14 PCRP SIDA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Prostate Cancer Synergistic Idea Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on May 6, 2014 and posted on May 6, 2014.
- Applicants must submit their applications by Sep 24, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $10,800,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 18 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Prostate Cancer Synergistic Idea Development Award is a funding opportunity under the Department of the Army's Congressionally Directed Medical Research Programs (CDMRP), specifically within the Prostate Cancer Research Program (PCRP). Its main purpose is to push prostate cancer research forward faster by backing genuinely new, high-impact ideas that come from close collaboration among two or three independent, faculty-level (or equivalent) principal investigators. The award is built around the idea that major breakthroughs often happen when experts from different backgrounds combine their strengths to tackle one shared, clearly defined problem in a way that would not be possible if each lab worked separately.
A defining feature of this mechanism is the emphasis on synergy. The investigators are expected to co-create a single, integrated research project with comparable intellectual leadership from each PI. While the project is shared, each PI is treated as a full principal investigator, submits a separate application package (even if all investigators are at the same institution), and receives an individual award. Reviewers are looking for projects where each PI brings unique expertise, tools, or perspectives that are essential to the overall approach, and where the collaborative structure clearly accelerates progress beyond what independent or loosely coordinated projects could achieve.
The program strongly prioritizes innovation. That means the proposed work should introduce a new paradigm, challenge existing assumptions, reframe a known problem in a creative way, or apply a novel method or cross-disciplinary strategy to prostate cancer research. Incremental extensions of already published work are explicitly not the goal. At the same time, the PCRP recognizes that innovative science can carry risk, so while preliminary data relevant to prostate cancer is encouraged, it is not required. Applicants still need to show that the concept is grounded in a solid scientific rationale, supported by logical reasoning and/or a thoughtful analysis of the existing literature.
In terms of scientific scope, the opportunity is intentionally broad and welcomes investigators from many disciplines, including basic science, engineering, bioinformatics, population science, translational research, and clinical research (with limits described below). Applicants are expected to address at least one of the PCRP focus areas and are strongly encouraged to address one of the PCRP overarching challenges. If a team chooses not to address an overarching challenge, the application is expected to clearly explain why the work still fills a critical gap for the field and/or improves patient care in a meaningful way.
Collaboration planning is not treated as an afterthought. Each proposed study must include clear, practical plans for how the investigators will interact and manage the collaboration, including communication routines, coordination of research activities, sharing of results, and data transfer. For multi-institutional collaborations, the program also requires an intellectual property plan. The point is to anticipate and resolve potential institutional barriers around intellectual and material property so that the partnership can operate smoothly and at a high level of cooperation throughout the award period.
Human subjects research is allowed, but clinical trials are not permitted under this mechanism. The opportunity does, however, encourage correlative studies tied to an existing clinical trial, as long as those correlative activities are judged to be no greater than minimal risk by the local IRB of record and by the USAMRMC Office of Research Protections (including HRPO review). The announcement also points applicants to a Human Subject Resource Document housed in the CDMRP eBRAP system for program-specific definitions and guidance around what counts as clinical research versus a clinical trial.
The PCRP also encourages teams to leverage existing PCRP-supported resources when relevant, particularly the Prostate Cancer Biorepository Network (PCBN) and the North Carolina-Louisiana Prostate Cancer Project (PCaP), especially when retrospectively collected human specimens or associated datasets could strengthen the proposed work. Beyond conducting the research itself, the CDMRP signals a strong expectation that data and research resources generated through funded awards should be shared with the wider research community (including consumer advocacy communities) and, broadly, the public, consistent with CDMRP guidance.
For the specific FY14 posting described, the opportunity was listed as Funding Opportunity Number W81XWH-14-PCRP-SIDA and was offered as a cooperative agreement/grant under CFDA 12.420 (Military Medical Research and Development). The program anticipated making about 18 awards with an estimated total funding level of $10.8 million, and it did not require cost sharing or matching funds. Eligibility was listed as unrestricted (open broadly to entity types, subject to any additional eligibility clarifications in the full announcement). The opportunity was posted May 6, 2014, with an application closing date of September 24, 2014, and it was archived October 24, 2014.
DoD Prostate Cancer Synergistic Idea Development Award (PCRP SIDA) FAQs
What is the DoD Prostate Cancer Synergistic Idea Development Award?
It is a funding opportunity within the Department of the Army's Congressionally Directed Medical Research Programs (CDMRP), under the Prostate Cancer Research Program (PCRP). The award is designed to speed progress in prostate cancer research by supporting genuinely novel, high-impact ideas developed through close collaboration among two or three independent, faculty-level (or equivalent) principal investigators (PIs).
What is the main goal of this award mechanism?
The core goal is to enable breakthroughs that are more likely to occur when experts from different backgrounds combine their strengths to tackle a single, clearly defined research problem in a way that would not be possible if each lab worked separately.
How many principal investigators can be on a team?
Teams are expected to consist of two or three independent PIs.
Who is considered an eligible PI for this opportunity?
The opportunity calls for independent, faculty-level (or equivalent) principal investigators. Each PI is expected to provide comparable intellectual leadership on the integrated project.
What does "synergy" mean in the context of this award?
Synergy is a defining feature of this mechanism. Reviewers are looking for a single, integrated project where each PI contributes unique expertise, tools, or perspectives that are essential to the overall approach, and where the collaboration accelerates progress beyond what independent or loosely coordinated projects could accomplish.
Does each PI submit one joint application, or separate applications?
Each PI is treated as a full principal investigator and submits a separate application package, even if all investigators are at the same institution. Each PI receives an individual award.
Is this award intended for incremental research?
No. The program strongly prioritizes innovation. Incremental extensions of already published work are explicitly not the goal.
What types of innovation are encouraged?
Proposals are expected to introduce a new paradigm, challenge existing assumptions, reframe a known problem in a creative way, or apply a novel method or cross-disciplinary strategy to prostate cancer research.
Is preliminary data required?
No. Preliminary data relevant to prostate cancer is encouraged but not required. Applicants are still expected to present a solid scientific rationale supported by logical reasoning and/or thoughtful analysis of existing literature.
What research areas and disciplines are eligible?
The scientific scope is intentionally broad and welcomes investigators from many disciplines, including basic science, engineering, bioinformatics, population science, translational research, and clinical research (subject to the limits described for clinical trials).
Do applications need to align with specific PCRP priorities?
Yes. Applicants are expected to address at least one of the PCRP focus areas and are strongly encouraged to address one of the PCRP overarching challenges.
What if a project does not address a PCRP overarching challenge?
If a team chooses not to address an overarching challenge, the application is expected to clearly explain why the work still fills a critical gap for the field and/or improves patient care in a meaningful way.
What collaboration planning is expected in the proposal?
Collaboration planning is required and must be practical and specific. Applications should include clear plans for how investigators will interact and manage the collaboration, including communication routines, coordination of research activities, sharing of results, and data transfer.
Are there additional requirements for multi-institution collaborations?
Yes. For multi-institutional collaborations, an intellectual property (IP) plan is required to anticipate and resolve potential institutional barriers related to intellectual and material property so the partnership can operate smoothly throughout the award period.
Is human subjects research allowed?
Yes. Human subjects research is allowed under this mechanism.
Are clinical trials allowed under this award?
No. Clinical trials are not permitted under this mechanism.
Are correlative studies connected to an existing clinical trial allowed?
Yes, correlative studies tied to an existing clinical trial are encouraged as long as the correlative activities are judged to be no greater than minimal risk by the local IRB of record and by the USAMRMC Office of Research Protections (including HRPO review).
Where can applicants find program-specific guidance on human subjects and clinical trial definitions?
The announcement directs applicants to a Human Subject Resource Document housed in the CDMRP eBRAP system for program-specific definitions and guidance, including what counts as clinical research versus a clinical trial.
Does the program encourage using existing PCRP resources?
Yes. Teams are encouraged to leverage PCRP-supported resources when relevant, particularly the Prostate Cancer Biorepository Network (PCBN) and the North Carolina-Louisiana Prostate Cancer Project (PCaP), especially for retrospectively collected human specimens or associated datasets.
Are awardees expected to share data and research resources?
Yes. CDMRP signals a strong expectation that data and research resources generated through funded awards will be shared with the wider research community (including consumer advocacy communities) and, broadly, the public, consistent with CDMRP guidance.
What is the Funding Opportunity Number for the FY14 posting described?
The Funding Opportunity Number listed for this FY14 opportunity is W81XWH-14-PCRP-SIDA.
What is the CFDA number associated with this opportunity?
The opportunity was offered under CFDA 12.420, Military Medical Research and Development.
How many awards were anticipated and what was the estimated total funding level?
The program anticipated making about 18 awards, with an estimated total funding level of $10.8 million.
Is cost sharing or matching funding required?
No. The FY14 posting indicated that cost sharing or matching funds were not required.
Who was eligible to apply?
Eligibility was listed as unrestricted, meaning it was open broadly to entity types, subject to any additional eligibility clarifications in the full announcement.
When was the opportunity posted, and what were the key dates?
The opportunity was posted on May 6, 2014. The application closing date was September 24, 2014. The listing was archived on October 24, 2014.
Is this opportunity currently open?
No. The specific FY14 posting described was archived on October 24, 2014.
What type of award instrument was used?
The FY14 posting described the award as a cooperative agreement/grant.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoD Prostate Cancer Idea Development Award
Previous opportunity: Enhancing situational awareness, surveillance, detection, risk assessment and response activities using a mapping and visualization tool
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 14 PCRP SIDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 14 PCRP SIDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Prostate Cancer Idea Development Award Apply for W81XWH 14 PCRP IDA Funding Number: W81XWH 14 PCRP IDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Compact High Density Tactical Energy Storage Apply for 14 SN 0012 Funding Number: 14 SN 0012 Agency: Office of Naval Research Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness New Investigator Award Apply for W81XWH 14 GWIRP NIA Funding Number: W81XWH 14 GWIRP NIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY15 PROJECT ON ADVANCED SYSTEMS AND CONCEPTS FOR COUNTERING WMD (PASCC) Apply for NPS BAA 14 003 Funding Number: NPS BAA 14 003 Agency: Naval Supply Systems Command Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2014 Mars Data Analysis Program Apply for NNH14ZDA001N MDAP Funding Number: NNH14ZDA001N MDAP Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Domestic Nuclear Detection Office Academic Research Initiative (ARI) Apply for DHS 14 DN 077 ARI 001 Funding Number: DHS 14 DN 077 ARI 001 Agency: Office of Procurement Operations Grants Division Category: Science and Technology and other Research and Development Funding Amount: $350,000 |
| ROSES 2014 Lunar Data Analysis Program Apply for NNH14ZDA001N LDAP Funding Number: NNH14ZDA001N LDAP Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| JFSP Primary Announcement (1 Task Statement) Apply for FA FON0014 0005 Funding Number: FA FON0014 0005 Agency: Bureau of Land Management Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Agreement for Research and Program Assistance at DoD Installations Supported by the Kansas City District Apply for NWK 14 0001 Funding Number: NWK 14 0001 Agency: Dept. of the Army Corps of Engineers Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Database Development for Cumberland Piedmont Network Vital Signs Monitoring Apply for P14AS00099 Funding Number: P14AS00099 Agency: National Park Service Category: Science and Technology and other Research and Development Funding Amount: $54,267 |
| Centers of Research Excellence in Science and Technology Apply for 14 565 Funding Number: 14 565 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| LUNAR AND PLANETARY INSTITUTE Apply for NNJ14ZKA001N Funding Number: NNJ14ZKA001N Agency: NASA Johnson Space Center Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| The USAID Development Innovation Accelerator BAA Apply for BAA DIA STIP 2014 Funding Number: BAA DIA STIP 2014 Agency: Agency for International Development Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| CRNBAA14 002 Apply for CRNBAA14 002 Funding Number: CRNBAA14 002 Agency: NSWC CRANE Category: Science and Technology and other Research and Development Funding Amount: $40,000 |
| CRNBAA14 003 HBCU MI ONLY Apply for CRNBAA14 003 Funding Number: CRNBAA14 003 Agency: NSWC CRANE Category: Science and Technology and other Research and Development Funding Amount: $80,000 |
| ROSES 2014 Atmospheric Composition Laboratory Research Apply for NNH14ZDA001N ACLS Funding Number: NNH14ZDA001N ACLS Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Chesapeake Watershed CESU Apply for G14AS00072 Funding Number: G14AS00072 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Colorado Plateau CESU Apply for G14AS00071 Funding Number: G14AS00071 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Rocky Mountain CESU Apply for G14AS00069 Funding Number: G14AS00069 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Colorado Plateau CESU Apply for G14AS00070 Funding Number: G14AS00070 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 14 PCRP SIDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
